Using blood test markers to predict pancreatitis severity
Part of Digestive system clinical trials.
This trial looks at whether routine blood test results can help doctors predict how severe acute pancreatitis will be and how well patients may recover. It aims to find simple, early clues to guide treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have been diagnosed with acute pancreatitis and treated at this hospital between January 2019 and March 2025.
- You do not have chronic kidney disease.
- You are not pregnant.
- You have no history of cancer or blood disorders.
- You do not currently have an active infection.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at whether a blood test that combines a type of white blood cell (neutrophil) and a kidney measure (creatinine) can help predict how severe acute pancreatitis is and what the outcome might be for patients.
This study uses a special device to listen to bowel sounds to help predict how severe acute pancreatitis will be. The goal is to find a simple, non-invasive way to guide treatment.
This study looks at specific blood “immune” signatures and how they relate to outcomes in people with acute pancreatitis. If you enroll early, it may help doctors better predict how the illness will go and identify who might need more care.
This trial uses a blood test to look for infection in people with a severe type of pancreatitis (inflammation of the pancreas). The goal is to see if the test can find infections faster and more accurately than current methods.
This study analyzes immune system markers in blood samples to help predict which people with chronic pancreatitis (long-term pancreas inflammation) might develop pancreatic cancer. Researchers will compare blood patterns in healthy people, those with chronic pancreatitis, and those recently diagnosed with pancreatic cancer.
This trial collects blood samples from people with infected pancreatic necrosis to find patterns that help diagnose the condition. The goal is to reduce the need for invasive tests and start treatment faster.
Hear when a new Acute Pancreatitis (AP) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.